Respiratory syncytial virus (RSV) is an enveloped, negative-sense, single-stranded RNA pneumovirus with 2 key surface glycoproteins, the fusion (F) protein and the attachment (G) protein, which are the principal targets...
Download Infographic Overview Encourages individuals to assess their risk of exposure to a specific disease before deciding on vaccination. Explains how to weigh disease risks against vaccine risks and benefits. Defines...
The January 2025 GNN monthly update reports on key NITAG and GNN activities and selected new recommendations in immunization policy. It notes the postponement of the planned in‑person GNN meeting in April 2025 but...
Overview The past week brought important signals on continental immunization strategies (Africa), local manufacturing (South Africa, India), next generation COVID-19 and mucosal vaccines (Europe, Asia–Pacific), and...
As the world reaches the midpoint of the Immunization Agenda 2030 (IA2030), immunization programs find themselves at an inflection point.1 The initial focus on recovering from pandemic-era backsliding is giving way to a...
Download Infographic Overview Climate change and increased human mobility are altering the risk patterns of vaccine-preventable diseases (VPDs). Rising temperatures, changing rainfall, and extreme weather events affect...
North America – Politics First, Evidence Second US vaccine policy spent the week in committee rooms and courtrooms, as reforms to ACIP processes and federal advisory structures drew fire from professional societies and...
“Shared decision‑making” sounds benign, even progressive. Who would object to clinicians and families talking through risks and benefits together? Yet as it is currently being applied to vaccination, “shared...